RELX Overview

RELX PLC is a United Kingdom-based global provider of information-based analytics and decision tools for professional and business customers. The Company operates in four market segments: Risk; Scientific, Technical & Medical; Legal, and Exhibitions. The Risk segment provides customers with information-based analytics and decision tools that combine public and industry-specific content with advanced technology and algorithms to assist them in evaluating and predicting risk and enhancing operational efficiency. The Scientific, Technical & Medical segment helps researchers and healthcare professionals advance science and improve health outcomes by combining high-quality scientific and medical information. The Legal segment provides legal, regulatory and business information and analytics. The Exhibitions segment combines industry expertise with data and digital tools to help customers connect face-to-face and digitally, learn about markets, source products and complete transactions.

Wall Street analysts forecast RELX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RELX is60.54 USD with a low forecast of 60.54 USD and a high forecast of 60.54 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Relx PLC revenue for the last quarter amounts to NaN USD, decreased

Relx PLC. EPS for the last quarter amounts to USD, decreased

Relx PLC (RELX) has 35720 emplpoyees as of March 11 2026.

Today RELX has the market capitalization of 63.24B USD.